Conditions: Narcolepsy
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 93
Healthy volunteers: no

Brief summary:
This is a study to evaluate the safety and effectiveness of ADX-N05 compared to placebo in the treatment of excessive daytime sleepiness in adults with narcolepsy.

Detailed description:

Arms:
arm 1: ADX-N05 to be taken once a day for 12 weeks arm 2: Placebo to match ADX-N05 to be taken once a day for 12 weeks

Interventions: intervention 1: ADX-N05 intervention 2: Placebo
Intervention descriptions: intervention 1: 150 mg once a day for 4 weeks followed by 300 mg once a day for 8 weeks intervention 2: One capsule placebo to match ADX-N05 to be taken for 4 weeks followed by 2 capsules placebo to match ADX-N05 to be taken for 8 weeks

Protocol document: